イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text







Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

ブログ
LIVE-Step Cell Assay System: Redefining Simplicity and Accuracy in High-throughput Cell Viability Assays
11月 21, 2024
ブログを読む
Cell Culture & Characterization
Antibodies
Protein Sciences
No items found.
ブログ
Enhancing Diversity in Clinical Trials: The Role of Systematic Literature Reviews in FDA's DEI Initiatives
11月 19, 2024
ブログを読む
Clinical Trials
No items found.
Market Access
No items found.

ブログ
Blood Proteomics: Revealing Clues About Immune Checkpoint Therapy Response
11月 18, 2024
スポンサー:
スポンサー
ブログを読む
Antibodies
Biomarkers
HBS
RayBiotech

ブログ
Precision in PBMC Isolation and Analysis: Driving Next-Gen Therapeutic Solutions
11月 14, 2024
スポンサー:
スポンサー
ブログを読む
Pharmacology
Cell Culture & Characterization
In Vitro Assays
Mediford Corporation

ブログ
To Be Humanized or Not to Be? That Is the Question for Camelid VHH Antibodies
11月 12, 2024
スポンサー:
スポンサー
ブログを読む
Antibodies
AvantGen

ブログ
ModEx: Revolutionizing Cancer Drug Pricing and Access Through Open-Source Health Economic Models
11月 8, 2024
スポンサー:
スポンサー
ブログを読む
Health Economics & Outcomes Research (HEOR)
ModEx
Clinical Trials
Market Access
No items found.

ブログ
Unlocking the Power of PDX Mouse Clinical Trials in Oncology Drug Development
10月 22, 2024
スポンサー:
スポンサー
ブログを読む
Biomarkers
Disease Models
Crown Bioscience
Health Economics & Outcomes Research (HEOR)
No items found.
Pharmacology
Cell Culture & Characterization
Clinical Trials
Danyi Wen
Shanghai LIDE Biotech Co., Ltd. (LIDE Biotech)
Scientist.com
Pharmacology
Disease Models
Andrea Bonetto
Aurora Scientific, Inc.
American Physiological Society
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
Market Access
Real-World Evidence (RWE)
Pierre Etienne
Michael Pace
Clifton Chow
Actu-Real
HealthEconomics.com
Pharmacology
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
M.S.M. Mujeebur Rahuman
Holger von Moeller
Fernando Huerta
Aragen
MOLOX
Research Institutes of Sweden
Scientist.com
Disease Models
E. Dale Abel
No items found.
American Physiological Society
Alliance for Aging Research
Bioimaging
Chemical & Compound Analysis
Robert E. A. Williams
Mark Riccio
Thermo Fisher Scientific
No items found.
Disease Models
Pharmacology
Gwendalyn J Randolph
No items found.
American Physiological Society
Autoimmune Association
Disease Models
Caroline Wuyts
Harvard Bioscience, Inc.
Data Sciences International
No items found.
Pharmacology
Bioimaging
Protein Sciences
Danny Chou
Yokogawa Fluid Imaging Technologies
No items found.
Pharmacology
Biomarkers
Manuel Mayr
Marco Tognetti
Oliver Rinner
Kanna Palaniappan
Biognosys
No items found.

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.




























.avif)








